BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35783198)

  • 1. Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.
    Habibullah MM; Mohan S; Syed NK; Makeen HA; Jamal QMS; Alothaid H; Bantun F; Alhazmi A; Hakamy A; Kaabi YA; Samlan G; Lohani M; Thangavel N; Al-Kasim MA
    Drug Des Devel Ther; 2022; 16():1963-1974. PubMed ID: 35783198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual cancer targeting using estrogen functionalized chitosan nanoparticles loaded with doxorubicin-estrone conjugate: A quality by design approach.
    Kurmi BD; Paliwal R; Paliwal SR
    Int J Biol Macromol; 2020 Dec; 164():2881-2894. PubMed ID: 32853621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
    Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
    Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico design of AVP (4-5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles.
    Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; E Ozel A; Akyuz S
    Daru; 2020 Jun; 28(1):139-157. PubMed ID: 31942695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Chitosan-Capped Gold Nanoparticles for enhanced cancer chemo-radiotherapy: An invitro study.
    Fathy MM; Mohamed FS; Elbialy N; Elshemey WM
    Phys Med; 2018 Apr; 48():76-83. PubMed ID: 29728233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
    Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
    Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies.
    Helmi O; Elshishiny F; Mamdouh W
    Int J Biol Macromol; 2021 Aug; 184():325-338. PubMed ID: 34119547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer targeted chemotherapy based on doxorubicin-loaded bombesin peptide modified nanocarriers.
    Wang C; Sun X; Wang K; Wang Y; Yang F; Wang H
    Drug Deliv; 2016 Oct; 23(8):2697-2702. PubMed ID: 26203692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells.
    Talaei F; Azizi E; Dinarvand R; Atyabi F
    Int J Nanomedicine; 2011; 6():1963-75. PubMed ID: 21976973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan-Dextran sulfate coated doxorubicin loaded PLGA-PVA-nanoparticles caused apoptosis in doxorubicin resistance breast cancer cells through induction of DNA damage.
    Siddharth S; Nayak A; Nayak D; Bindhani BK; Kundu CN
    Sci Rep; 2017 May; 7(1):2143. PubMed ID: 28526868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
    Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
    Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles.
    Varshosaz J; Hassanzadeh F; Aliabadi HS; Khoraskani FR; Mirian M; Behdadfar B
    Int J Biol Macromol; 2016 Dec; 93(Pt A):1192-1205. PubMed ID: 27693338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of DNAzyme Loaded on Chitosan/Cyclodextrin Nanoparticle to Recovery of Chemosensitivity in the MCF-7 Cell Line.
    Zokaei E; Badoei-Dalfrad A; Ansari M; Karami Z; Eslaminejad T; Nematollahi-Mahani SN
    Appl Biochem Biotechnol; 2019 Mar; 187(3):708-723. PubMed ID: 30039475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-loaded piperlongumine nanoparticles and kaempferol enhance the anti-cancer action of doxorubicin in targeting of Ehrlich solid adenocarcinoma: in vivo and in silico modeling study.
    Ibrahim FAR; Hussein NA; Soliman AYM; Shalaby TI; Rashad MM; Matar NA; El-Sewedy TS
    Med Oncol; 2024 Jan; 41(2):61. PubMed ID: 38253759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
    Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Al-Husein BA
    Curr Cancer Drug Targets; 2022; 22(2):133-141. PubMed ID: 35081892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study.
    Kaur H; Ghosh S; Kumar P; Basu B; Nagpal K
    Life Sci; 2021 Nov; 284():119927. PubMed ID: 34492262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin.
    Khdair A; Hamad I; Alkhatib H; Bustanji Y; Mohammad M; Tayem R; Aiedeh K
    Eur J Pharm Sci; 2016 Oct; 93():38-44. PubMed ID: 27473308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
    Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
    Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.